Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Datadog
AN
AnalystConsensusTarget
Consensus Narrative from 40 Analysts
Enterprise Cloud Migration And AI Adoption Will Fuel Digital Transformation
Key Takeaways Robust demand for unified observability and security amid complex cloud trends, with product innovation and consolidation reinforcing Datadog's customer retention and top-line growth. Strategic international expansion and operational cost optimization are driving sustained profitability improvements and diversifying Datadog's market opportunities.
View narrative
US$160.06
FV
19.4% undervalued
intrinsic discount
19.92%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
121
users have followed this narrative
5 days ago
author updated this narrative
Godrej Properties
AN
AnalystLowTarget
Consensus Narrative from 20 Analysts
Urban Plateau And Regulatory Delays Will Hamper New Projects
Key Takeaways Heavy reliance on premium urban markets increases vulnerability to saturation, cyclical risk, and operational complexity, threatening margins and consistent growth. Regulatory delays, compliance burdens, and rising competition risk eroding pricing power and stalling both top-line and net profit expansion.
View narrative
₹1.75k
FV
14.4% overvalued
intrinsic discount
21.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Ipsen
AN
AnalystLowTarget
Consensus Narrative from 14 Analysts
US And EU Controls And Pipeline Risks Will Erode Outlook
Key Takeaways Heightened drug pricing pressure and mounting regulation threaten future revenue growth and margin stability, with rising compliance costs and delayed product launches. Heavy dependence on a concentrated product portfolio and limited pipeline differentiation increase vulnerability to competition, market stagnation, and volatility in earnings.
View narrative
€105.00
FV
8.5% overvalued
intrinsic discount
2.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
SGH
SGH
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Reshoring Pressures And Regulatory Hurdles Will Weigh On Prospects
Key Takeaways Increasing regionalization, regulatory hurdles, and industry consolidation threaten SGH's revenue growth, market access, and long-term profitability prospects. Reliance on cyclical sectors and product commoditization could erode pricing power and margins if economic conditions worsen or competition intensifies.
View narrative
AU$40.77
FV
18.3% overvalued
intrinsic discount
4.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Stevanato Group
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Rising Regulatory Costs And Local Rivalry Will Compress Margins
Key Takeaways Heightened regulatory and market shifts threaten Stevanato's product relevance, margins, and demand, forcing potential redesigns and eroding pricing power. Rising local competition and evolving drug delivery technologies risk undercutting global expansion efforts and diminishing returns from recent investments.
View narrative
US$23.00
FV
1.8% undervalued
intrinsic discount
8.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Türk Hava Yollari Anonim Ortakligi
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Operational And Geopolitical Risks Will Challenge Airlines Yet Spur Resilience
Key Takeaways Geopolitical instability, volatile demand, and currency risks threaten long-term earnings visibility and profitability despite growing passenger traffic and digital initiatives. Ambitious fleet expansion and increased competition heighten financial risk and operating costs, while industry changes pressure key revenue segments and margin growth.
View narrative
₺331.00
FV
0.9% overvalued
intrinsic discount
0.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
XPEV
XPeng
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Tariffs And Supply Chain Woes Will Erode EV Margins
Key Takeaways Global protectionism and rising tariffs may hinder overseas expansion and limit revenue diversification, impacting future growth prospects. High costs for R&D and intensified price competition threaten profitability, while slow adoption of advanced features could constrain software-related revenue.
View narrative
US$18.05
FV
10.3% overvalued
intrinsic discount
28.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
WPP
AN
AnalystLowTarget
Consensus Narrative from 11 Analysts
Digital Walled Gardens Will Erode Traditional Agency Revenues
Key Takeaways Dominance of digital platforms and in-house AI solutions is shrinking WPP's market relevance, pressuring revenue growth and long-term client retention. Struggles with digital transformation and tighter data privacy rules drive declining sales, unpredictable earnings, and persistent margin pressure.
View narrative
UK£3.70
FV
2.3% overvalued
intrinsic discount
-13.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
10 days ago
author updated this narrative
Fresenius Medical Care
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
The Shift To Home Dialysis Will Erode Core Revenues
Key Takeaways Shifting market dynamics and emerging therapies threaten the company's reliance on traditional in-center dialysis, risking long-term revenue stability and growth. Regulatory, reimbursement, and quality pressures are expected to compress margins and increase compliance costs, further weighing on the company's profitability.
View narrative
€40.00
FV
6.9% overvalued
intrinsic discount
2.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
10 days ago
author updated this narrative
Value any company in seconds
Popular companies